While the Trump administration may be hoping that the headwinds in creating for academic hiring may push recent graduates or newly minted PhDs into the private industry, it's unlikely to play out that way because of the speed and scale of the disruption. "Pharmaceutical firms are not going to suddenly open up more jobs for graduates to adapt to this situation," said Ding. "More likely is that people will start looking for opportunities outside the United States or wind up without jobs altogether. At this point, it's still too early to say if these are the first signs of losing a generation of scientists." But even people like Ding who track the data that could provide clues about how extensive the damage will be are facing uncertainty about their ability to continue their own work. Her plan to hire a postdoc are currently on hold is she waits to find out if a grant she has through the National Science Foundation, which is facing its own dramatic cuts, will come through.🏁

While the Trump administration may be hoping that the headwinds in creating for academic hiring may push recent graduates or newly minted PhDs into the private industry, it's unlikely to play out that way because of the speed and scale of the disruption. "Pharmaceutical firms are not going to suddenly open up more jobs for graduates to adapt to this situation," said Ding. "More likely is that people will start looking for opportunities outside the United States or wind up without jobs altogether. At this point, it's still too early to say if these are the first signs of losing a generation of scientists." But even people like Ding who track the data that could provide clues about how extensive the damage will be are facing uncertainty about their ability to continue their own work. Her plan to hire a postdoc are currently on hold is she waits to find out if a grant she has through the National Science Foundation, which is facing its own dramatic cuts, will come through.🏁